The Junk Science Problem in Drug Testing Is Bigger Than False Positives

A New Forensic Review Shows Why Detecting a Drug in Hair Does Not Prove How It Got There, How Much Was Used, or Whether It Was Intentionally Consumed

The Problem Is Not Just Whether the Test Is “Positive”

For years, I have questioned the reliability of enzyme immunoassay testing and the various immunoassay methodologies used by government employers and private laboratories to identify alleged drug use. Much of that debate focuses on false positives, cross-reactivity, laboratory error, contamination, cutoff concentrations, and whether an initial immunoassay result is adequately confirmed through a more specific analytical method.

Those issues remain important, but they do not address the most consequential scientific question: what does the result actually prove about the conduct of the person being tested?

A laboratory may correctly identify a chemical compound in hair and still lack a scientifically reliable basis to determine how that compound got there, how much of the drug was consumed, how frequently it was consumed, or whether it was intentionally consumed at all.

A 2026 review published in Science & Justice, “The forensic limits of hair drug testing: a critical assessment of drug intake and hair concentration relationships,” examined that problem directly. The authors assessed controlled-administration studies involving both illicit substances and pharmaceuticals to determine whether a reliable relationship exists between the amount of drug ingested and the concentration later measured in hair.

Their conclusion substantially limits the forensic meaning of hair testing. The available evidence supports using hair as a qualitative indicator of exposure, but not as a reliable quantitative measure of drug intake. The review also concludes that hair analysis cannot reliably distinguish intentional ingestion from passive contact.

That distinction matters because employment drug-testing systems generally do far more than establish exposure. They convert a laboratory result into a determination that the employee intentionally consumed an illegal substance and therefore committed misconduct.

The science does not necessarily support that leap.

The Dose-Concentration Relationship Is Not Reliable

For quantitative hair testing to have meaningful forensic value, there must be a sufficiently reliable relationship between the amount of drug consumed and the concentration ultimately measured in hair.

The review found that controlled studies involving heroin, codeine, amphetamine, cannabis, gamma-hydroxybutyrate, and other drugs of abuse produced weak, inconsistent, or nonexistent correlations between administered dose and measured hair concentration. Although certain pharmaceuticals, including methadone and clozapine, showed more meaningful associations under particular conditions, those findings were compound-specific and did not translate into a generally reliable model for illicit drug use.

The review also identified substantial overlap between concentrations measured in low-dose and high-dose subjects. That is particularly important because it directly undermines the assumption that a reported hair concentration can be used to reconstruct how much of a drug someone consumed.

A laboratory may accurately measure how much analyte it recovered from a specimen. That does not mean it can accurately determine how much drug entered the person’s body.

The distinction between analytical precision and biological interpretation is critical. A concentration reported in picograms or nanograms per milligram may look exact, but if people receiving materially different doses can produce overlapping concentrations, the reported number cannot reliably function as a retrospective dosage meter.

Melanin Can Change the Concentration Without Changing the Dose

The pigmentation issue makes quantitative interpretation even more problematic.

Basic drugs bind strongly to eumelanin, which is present in greater concentrations in darker hair. The literature reviewed in this field indicates that individuals with more heavily pigmented hair can incorporate dramatically greater concentrations of certain drugs than individuals with lighter or chemically treated hair despite receiving the same dose. In some studies, the difference reportedly reaches approximately fifteen-fold.

That is not a minor source of laboratory variation.

If two people receive the same dose and one person’s hair incorporates many times the concentration measured in the other’s hair because of pigmentation, then the concentration cannot be treated as a neutral measure of consumption. It reflects not only exposure to the drug, but also the biological characteristics of the hair itself.

That becomes especially significant where an employer applies one numerical cutoff across a diverse workforce and assumes that the same concentration carries the same forensic meaning for everyone.

Procedural uniformity does not establish biological equivalence.

The 2026 review expressly identifies melanin as a confounding factor and recommends additional work directed toward correcting for melanin content. If the scientific community itself continues to identify melanin correction as an unresolved methodological issue, government employers should not be permitted to pretend the variable has no practical significance when those same test results are used to impose discipline.

Hair Does Not Acquire Drugs Through One Pathway

The biological model is also more complicated than simply assuming that a person consumes a drug, the drug enters the bloodstream, and a predictable amount becomes incorporated into growing hair.

Drugs can reach hair through sweat and sebum after the hair emerges from the scalp, and those secretions may contain drug concentrations greater than those circulating in blood. Environmental contamination presents an additional pathway.

The final concentration measured in a specimen may therefore reflect some combination of systemic incorporation, sweat, sebum, environmental contact, and other processes rather than a single biological pathway directly tied to ingestion.

That is why the review’s conclusion concerning passive contact is so important. The authors state that current evidence allows hair analysis to establish exposure but does not permit reliable discrimination between intentional ingestion and passive contact.

For an employer alleging misconduct, that limitation goes directly to culpability. An employee is not generally disciplined because a drug was somehow associated with a hair specimen. The allegation is intentional use. If the testing methodology cannot reliably distinguish intentional ingestion from other recognized pathways of incorporation, the laboratory result cannot simply be treated as conclusive proof of misconduct.

Cosmetic Treatment Can Move the Number in the Other Direction

The instability of hair concentration becomes even clearer when cosmetic treatment is considered.

Bleaching, dyeing, repeated washing, and related chemical treatments can materially reduce drug concentrations in hair. Published findings cited in this area include reductions of approximately 36.9 percent for amphetamines, approximately 25 percent for cocaine, and reductions approaching 89 percent for heroin under particular treatment conditions.

Those numbers demonstrate something important: the person’s historical conduct has not changed, yet the laboratory concentration can change dramatically because the hair was chemically treated.

A person with the same underlying exposure may therefore produce a materially different result depending upon whether the hair was untreated, bleached, dyed, or repeatedly washed. In some circumstances, that difference may be large enough to move the specimen across a testing cutoff.

The consequence is difficult to reconcile with the notion that hair concentration provides a stable historical measurement of drug consumption. Pigmentation may increase concentrations, while cosmetic treatment may sharply reduce them, even though neither variable necessarily reflects any difference in intentional drug use.

Laboratory Methodology Adds Another Layer of Variability

The review also identifies methodological inconsistencies involving decontamination procedures, washing protocols, extraction methods, segment selection, and storage conditions.

Those differences matter because they can influence the concentration ultimately reported. Different washing procedures may remove different amounts of externally deposited or hair-associated drug. Extraction techniques may recover different quantities of analyte. Segment selection affects the period supposedly represented by the specimen. Storage conditions can affect analyte stability before testing begins.

This creates a reproducibility problem.

A laboratory may follow its own internal procedure consistently, but consistency within one laboratory does not establish that the broader methodology is scientifically reliable for the forensic proposition being asserted. If materially different preparation and analytical procedures produce materially different results, the concentration cannot simply be treated as universally interpretable.

The review specifically identifies methodological inconsistency, along with melanin, sweat, and cosmetic treatment, as factors undermining reliable dose estimation and calls for greater standardization of analytical protocols.

Confirmation Does Not Fix the Biological Problem

This is where reliance upon GC-MS, LC-MS/MS, or another confirmatory technique is often overstated.

Mass-spectrometric confirmation can substantially improve analytical specificity and provide greater confidence that the target compound or metabolite is actually present in the specimen. That is important, particularly where an initial immunoassay may be susceptible to cross-reactivity.

But confirmation does not answer every forensic question.

It cannot determine whether melanin caused one person’s hair to incorporate significantly more drug than another person’s hair after the same dose. It cannot determine what portion of the measured concentration entered through blood, sweat, sebum, or external contact. It cannot reverse changes produced by cosmetic treatment. It cannot eliminate methodological differences in washing, extraction, segmentation, or storage.

Most importantly, it cannot create a reliable dose-concentration relationship where controlled studies have failed to establish one.

The confirmatory instrument may tell the laboratory what chemical is present. It does not necessarily tell the employer what the employee did.

That distinction is central to my continuing criticism of immunoassay-based drug-testing systems. Even if an initial immunoassay correctly flags the specimen, and even if subsequent mass spectrometry correctly identifies the target analyte, the ultimate conclusion of intentional drug use may still exceed what the science permits.

A Laboratory Result Should Not Be Allowed to Prove More Than the Science Supports

The junk-science problem in drug testing is therefore much larger than false positives.

The more serious problem arises when a chemically accurate laboratory result is converted into a behavioral conclusion that the biological matrix cannot reliably support. That becomes especially troubling when government employers use hair testing to terminate employees, impose discipline, deny promotions, revoke credentials, or permanently characterize individuals as illegal drug users.

Once a test is used for those purposes, it has moved beyond screening and become an adjudicative instrument. At that point, the relevant scientific question is not merely whether the laboratory followed its procedures or correctly identified a compound. The question is whether the method has been validated for the proposition the government intends to prove.

The 2026 Science & Justice review ultimately concludes that hair should be treated as a qualitative indicator of exposure rather than a quantitative measure of drug intake. That conclusion goes directly to the difference between detecting a chemical and proving misconduct.

A laboratory may establish that a drug was detected in hair while remaining unable to establish how it got there, how much was consumed, how frequently it was consumed, or whether the person intentionally consumed it at all.

When someone’s career and livelihood depend upon the answer, that distinction is not technical. It is the entire case.

About the Author